Davis Polk advised Charles River Laboratories International, Inc. in connection with its Rule 144A/Regulation S offering of $500 million aggregate principal amount of 5.500% senior notes due 2026. The notes are guaranteed by certain of Charles River’s U.S. subsidiaries that are guarantors under its revolving credit facility.

Charles River is a Wilmington, Massachusetts-based global provider of research models and associated services and of preclinical drug development services. The company provides services to assist pharmaceutical and biotechnology companies, government agencies and leading academic institutions worldwide with enhancing their research and drug development efforts through in-human evaluation of new products and employs over 11,000 employees worldwide.

The Davis Polk capital markets team included partner Richard D. Truesdell Jr., counsel Jeffrey S. Ramsay and associate Yoojin L. Kim. The tax team included partner Michael Mollerus and associate Gil Savir. Counsel David A. Zilberberg provided environmental advice. Partner Frank J. Azzopardi and associate Jay Frankel provided intellectual property and technology advice. All members of the Davis Polk team are based in the New York office.

Copy link to share post